COVID-19 in a patient with idiopathic pulmonary fibrosis successfully treated with Ruxolitinib - 06/11/20
This article has been published in an issue click here to access
Keywords : SARS-CoV-2, Covid-19, JAK inhibitors, idiopathic pulmonary fibrosis
El texto completo de este artículo está disponible en PDF.
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.